A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WITHOUT A RECENT HISTORY OF BLOOD TRANSFUSION

Registry ID

BIVV009-04

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

BIOVERATIV USA INC

Start date

2018-02-16

Last update

2017-12-15

Conditions

• COLD AGGLUTININ DISEASE

Related clinical trials

• A MULTICENTER, PHASE 1B, OPEN LABEL, NONRANDOMIZED, SINGLE DOSE STUDY EVALUATING THE SAFETY, TOLERABILITY AND ACTIVITY OF BIVV020 IN ADULTS WITH COLD AGGLUTININ DISEASE

View on source registry